Sandbox hemophillus

Revision as of 17:42, 17 May 2017 by Aditya Ganti (talk | contribs) (Created page with "==Pathophysiology== ===Transmission=== *Transmission is by direct contact or by inhalation of respiratory tract droplets. *Neonates can acquire infection by aspiration of amni...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Pathophysiology

Transmission

  • Transmission is by direct contact or by inhalation of respiratory tract droplets.
  • Neonates can acquire infection by aspiration of amniotic fluid or contact with genital tract secretions containing the bacteria.

Seeding

  • A larger bacterial load or the presence of a concomitant viral infection can potentiate the infection.
  • The colonizing bacteria invade the mucosa and enter the bloodstream.
  • The spread of bacteria by direct extension to the eustachian tubes causes otitis media.
  • Spread to the sinuses leads to sinusitis.
  • Spread down the respiratory tract results in bronchitis and pneumonia.
  • Eustachian tube dysfunction, antecedent viral upper respiratory tract infection (URTI), foreign bodies, and mucosal irritants, including smoking, can promote infection.
  • In patients with underlying chronic obstructive pulmonary disease (COPD) or cystic fibrosis (CF), NTHi frequently colonizes the lower respiratory tract and can exacerbate the disease.

Pathogenesis

  • The antiphagocytic nature of the Hib capsule and the absence of the anticapsular antibody lead to increasing bacterial proliferation.
  • When the bacterial concentration exceeds a critical level, it can disseminate to various sites, including meninges, subcutaneous tissue, joints, pleura, pericardia, and lungs.
  • The antibody to the Hib capsule plays the primary role in conferring immunity.
  • Newborns have a low risk of infection, likely because of acquired maternal antibodies.
  • When these transplacental antibodies to the PRP antigen wane, infants are at high risk of developing invasive H influenzae disease, and their immune responses are low even after the disease.
  • Therefore, they are at high risk of repeat infections since prior episodes of H influenzae do not confer immunity. By age 5 years, most children have naturally acquired antibodies.
  • The Hib conjugate vaccine induces protection by inducing antibodies against the PRP capsule.
  • The Hib conjugate vaccine does not provide protection against NTHi strains. Since the widespread use of the Hib conjugate vaccine, NTHi has become more of a pathogen.